Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.
about
Nausea: a review of pathophysiology and therapeuticsProphylactic Management of Radiation-Induced Nausea and VomitingPalonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapyTreatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and VomitingDrug-drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical dataPalonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials.Effect of acupuncture in prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: study protocol for a randomized controlled trial.Thermoregulatory correlates of nausea in rats and musk shrews.Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.Nausea in specific phobia of vomiting.Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence.Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlatesAprepitant and fosaprepitant: a 10-year review of efficacy and safetyEffect of rikkunshi-to treatment on chemotherapy-induced appetite loss in patients with lung cancer: A prospective study.Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs Used in Cancer Treatment in a Tertiary Care HospitalGenotype frequencies for polymorphisms related to chemotherapy-induced nausea and vomiting in a Japanese population.At cancer diagnosis: a 'window of opportunity' for behavioural change towards physical activity. A randomised feasibility study in patients with colon and breast cancerAcetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar University Referral Hospital, Ethiopia: a cross-sectional study.Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.Olanzapine for the Prevention of Chemotherapy-Induced Nausea and VomitingPrevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.Pharmacogenetics of chemotherapy-induced nausea and vomiting.Update on the management of chemotherapy-induced nausea and vomiting - focus on palonosetron.Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management.Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer.Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis.Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of 'overall' nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients.Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
P2860
Q26771877-E4F8D42E-94B0-44EB-B1C3-D5C218D81985Q26783184-F1ED1C31-941C-437A-8FF1-DEC7FBEA2802Q26783229-F643EA2A-AFA5-42D6-A802-2E1F946A5BD3Q26784070-1E83A372-059C-42FE-BFA7-D268339373E7Q28084970-99BC1C9A-4543-4DDB-AE2D-66A9DB9FE34FQ30672833-AF142445-D8B2-40F8-A3A1-1FC6030D3C26Q33587206-CD0CFA13-5837-4827-A91C-09BE1E6964F2Q33688928-90900711-2B68-4207-8503-84DA724DB2CBQ33866119-27B9A0B8-857B-4854-A9BB-71F586F58CAEQ34166946-66539595-E7D2-47A4-B31F-9BBB129AAB1CQ34443057-1FE836CC-AA1A-4C16-92F4-43D6494A32C4Q34512212-14BE45BA-5B48-4CA7-91DA-8527C594F83EQ34775395-7B00F0B9-62FA-4B71-8803-987881848697Q35164623-8232AA15-91F9-4237-BEF8-EBDD5E2FA4F6Q35345557-A536B90B-9E9F-4E34-B9A8-489B708601FBQ36502184-34E32F59-20E8-4794-B4DE-451261488CB9Q36651515-45413185-1D9A-4676-9B7B-F2ADF249EB57Q37113282-C55B8B7F-8F50-4628-95E7-5390645BE251Q37293242-7DAD7089-524A-4DE6-B99D-F61A7564006BQ37301431-D6C01904-4ED0-491D-AAF8-F64C0B8BA9A4Q37452743-423A0FB6-D72A-468B-8E02-8AB1B1629582Q37496403-0B4AF4EC-6B2B-4E57-AFC3-F6EEB26B8A50Q37625445-2A3A7CFF-9A56-40B3-9A50-653696DE9B9DQ37691654-FA71801F-205E-44C6-AC06-7C4D246EC279Q37736060-8EAF427D-D3DD-4BF9-AE80-62B48938DBEFQ38187578-0A44F739-64F8-4F49-B78E-E8C24A214D1BQ38208999-DF7219E4-1657-462F-9ED7-C8652917B32AQ38260952-C5A86F50-D421-4F44-8925-D45F6ACCE11CQ38264147-CCA36F55-1D8B-46D6-9AE1-2F83EE4A149CQ38330216-E11DB896-8485-4ED8-AE4C-A42C3A1D2963Q38497106-1958BB99-C1BC-4E24-A886-2F5E087C190BQ38574240-B41DE265-5C3A-4146-B804-A6B7078C7C58Q38650400-22B2B8D7-A2A6-434C-BA1F-0D94FC52CA15Q38677762-6315826D-7E35-46A3-BE6F-13D5B440623DQ38722201-AAA2F751-8C4C-47DB-9062-0DEC8E5C14D2Q38852352-EB0078CE-9E0D-4428-B517-C9A48BAF9D72Q38994391-D0DFB7CC-6E63-481A-BA90-DA82C51F0EA6Q39266110-1332D161-4CDA-493C-8CCD-043D216E2C1BQ39711625-65ECE38E-E238-47AC-B663-1E62D73A985EQ40542547-D0F6BBA7-81E5-4896-A504-66BC885FA9EE
P2860
Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Management of chemotherapy-ind ...... and new uses for older agents.
@ast
Management of chemotherapy-ind ...... and new uses for older agents.
@en
Management of chemotherapy-ind ...... and new uses for older agents.
@nl
type
label
Management of chemotherapy-ind ...... and new uses for older agents.
@ast
Management of chemotherapy-ind ...... and new uses for older agents.
@en
Management of chemotherapy-ind ...... and new uses for older agents.
@nl
prefLabel
Management of chemotherapy-ind ...... and new uses for older agents.
@ast
Management of chemotherapy-ind ...... and new uses for older agents.
@en
Management of chemotherapy-ind ...... and new uses for older agents.
@nl
P2860
P1433
P1476
Management of chemotherapy-ind ...... and new uses for older agents.
@en
P2093
Rudolph M Navari
P2860
P2888
P304
P356
10.1007/S40265-013-0019-1
P577
2013-03-01T00:00:00Z
P6179
1025059057